Home › GLP-1 Medications › Eli Lilly › Byetta
Latest three-month snapshot through 2026-08-05 · 1 wave. Use the controls above to change the window.
GLP-1 Medications · 1 wave · n=72 answers, pooled
How often each model brings the brand up in recommendation answers.
| model | share of voice | answers |
|---|---|---|
| ChatGPT | 0% | 0 of 24 |
| Claude | 29% | 7 of 24 |
| Gemini | 0% | 0 of 24 |
Wave-by-wave share of recommendation answers that named this brand.
| wave | share of voice | answers | change |
|---|---|---|---|
| 2026-08-05 | 10% | 7 of 72 |
Recurring descriptions in the models' own words, grouped by theme.
“It is a highly cost-effective GLP-1 option, though it does require twice-daily injections instead of once-daily.”
“**Discontinued:** Byetta and Bydureon (exenatide) were discontinued by the manufacturer in October 2024, though generic exenatide is now available.”
“Generic Exenatide (Generic Byetta): Exenatide was the first-ever GLP-1 drug. A generic version (referencing Byetta) is available”
“It helps manage blood sugar in type 2 diabetes, and while Byetta needs two injections a day, Bydureon Bcise only needs one injection a week.”
“- **Byetta/Bydureon (exenatide)** – also available generically.”
“It is a highly cost-effective GLP-1 option, though it does require twice-daily injections instead of once-daily.”
“* **Generic Exenatide (generic Byetta):** Generic exenatide is another daily or twice-daily injection option for Type 2 diabetes that is significantly less expensive than brand-name GLP-1s.”
“- **Exenatide (Byetta, Bydureon)** – daily or weekly injection”
“- **Dulaglutide** (*Trulicity*) and **exenatide** (*Byetta*, *Bydureon*) – older options, generally used for diabetes.”
“* **Generic Exenatide (Generic Byetta):** Exenatide was the first-ever GLP-1 drug.”
22 exact quoted mentions in this snapshot, grouped by coded tone. Recent quotes are deduplicated and mixed across models.
“**Generic Exenatide (generic Byetta):** Generic exenatide is another daily or twice-daily injection option for Type 2 diabetes that is significantly less expensive than brand-name GLP-1s.”
“Generic Exenatide (Generic Byetta): Exenatide was the first-ever GLP-1 drug. A generic version (referencing Byetta) is available”
“available as Byetta (two injections a day) or Bydureon Bcise (one injection a week), and helps manage blood sugar in type 2 diabetes.”
“exenatide (generic for Byetta)”
“Byetta/Bydureon (exenatide) – also available generically. It helps manage blood sugar in type 2 diabetes, and while Byetta needs two injections a day, Bydureon Bcise only needs one injection a week.”
“Other GLP-1 medications approved for type 2 diabetes include Rybelsus (semaglutide), Mounjaro (tirzepatide), Trulicity (dulaglutide), Bydureon BCise (exenatide) and Byetta (exenatide). These aren't necessarily cheaper out-of-pocket, but ins”
“**Exenatide (Byetta, Bydureon)** – daily or weekly injection”
“Generic Exenatide (formerly Byetta): The FDA approved generic exenatide. Like liraglutide, it is an older-generation GLP-1. The main downside is that it is typically injected twice daily (before meals) compared to Victoza's once-daily injec”
“**Generic exenatide (Byetta equivalent)**”
“Exenatide was the first GLP-1 approved for type 2 diabetes. Although the brand-name Byetta was discontinued, Amneal Pharmaceuticals manufactures a generic version (exenatide injection). It is a highly cost-effective GLP-1 option, though it ”
“these were discontinued by AstraZeneca in October 2024”
“Generic exenatide is available at a lower cost, though the twice-daily dosing makes Byetta less convenient than once-weekly options. It also lacks the proven cardiovascular benefits seen with newer GLP-1 drugs and doesn't produce weight los”
“Byetta and Bydureon (exenatide) were discontinued by the manufacturer in October 2024”
Which competitors models suggest when shoppers ask for something cheaper.
4 of 22 mentions appear alongside an identifiable web citation. Citation does not establish causation.
| cited source | mentions |
|---|---|
| fda.gov | 2 |
| sesamecare.com | 2 |
| amneal.com | 1 |
| clearscript.org | 1 |
| proactrx.com | 1 |
| epocrates.com | 1 |
| drugs.com | 1 |
| biopharminternational.com | 1 |
| rxinsider.com | 1 |
| healthesystems.com | 1 |
| amnealexenatide.com | 1 |
Method: fixed shopper questions asked repeatedly to Claude, OpenAI GPT and Gemini with web search on. Shares are the percentage of recommendation answers mentioning the brand. Quotes are AI outputs; full transcripts are kept as receipts.